يعرض 1 - 2 نتائج من 2 نتيجة بحث عن '"Julian Walter Holch"', وقت الاستعلام: 1.06s تنقيح النتائج
  1. 1
    Relation of cetuximab-induced skin toxicity and early tumor shrinkage in metastatic colorectal cancer patients: results of the randomized phase 3 trial FIRE-3 (AIO KRK0306)

    المؤلفون: Tobias Heintges, J. C. von Einem, Swantje Held, Christoph Kahl, Florian Kaiser, Marlies Michl, Alexander Kiani, Werner Scheithauer, L. Fischer von Weikersthal, Markus Moehler, Volker Heinemann, Frank Kullmann, Thomas Decker, Julian Walter Holch, Sebastian Stintzing

    المصدر: Annals of Oncology. 31:72-78

    مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_specialty, Bevacizumab, Cetuximab, Colorectal cancer, business.industry, Hazard ratio, Hematology, medicine.disease, medicine.disease_cause, digestive system diseases, Irinotecan, 03 medical and health sciences, Folinic acid, 030104 developmental biology, 0302 clinical medicine, 030220 oncology & carcinogenesis, Internal medicine, medicine, FOLFIRI, KRAS, business, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::079e82de852bda7021bd410425d991caTest
    https://doi.org/10.1016/j.annonc.2019.10.001Test


    أضف إلى المفضلة
  2. 2
    Relevance of baseline carcinoembryonic antigen for first-line treatment against metastatic colorectal cancer with FOLFIRI plus cetuximab or bevacizumab (FIRE-3 trial)

    المؤلفون: Ingrid Ricard, J. C. von Einem, Christoph Kahl, Christoph B. Westphalen, Werner Scheithauer, Marlies Michl, M. Moehler, Ursula Vehling-Kaiser, Dominik Paul Modest, Sebastian Stintzing, Tobias Heintges, Ivan Jelas, Alexander Kiani, Frank Kullmann, Volker Heinemann, L. Fischer von Weikersthal, Thomas Decker, Julian Walter Holch

    المصدر: European journal of cancer (Oxford, England : 1990). 106

    مصطلحات موضوعية: 0301 basic medicine, Male, Cancer Research, Time Factors, Colorectal cancer, Leucovorin, Cetuximab, medicine.disease_cause, Gastroenterology, 0302 clinical medicine, Carcinoembryonic antigen, Risk Factors, Antineoplastic Combined Chemotherapy Protocols, Multicenter Studies as Topic, Randomized Controlled Trials as Topic, biology, Hazard ratio, Middle Aged, Progression-Free Survival, Up-Regulation, Bevacizumab, Oncology, 030220 oncology & carcinogenesis, FOLFIRI, Female, KRAS, Fluorouracil, Colorectal Neoplasms, medicine.drug, Adult, medicine.medical_specialty, 03 medical and health sciences, Internal medicine, medicine, Humans, neoplasms, Aged, Retrospective Studies, business.industry, Odds ratio, medicine.disease, digestive system diseases, Carcinoembryonic Antigen, 030104 developmental biology, Clinical Trials, Phase III as Topic, biology.protein, Camptothecin, business

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db427639897a9a8442afe5d29fcf7f1fTest
    https://pubmed.ncbi.nlm.nih.gov/30496943Test


    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث